U.S. Markets closed
LISTEN

Schultz: Businesses need to do more to help people

Yahoo Finance's Julia La Roche sits down with executive chairman and former CEO of Starbucks Howard Schultz

Ironwood Pharmaceuticals, Inc. (IRWD)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
15.84+0.32 (+2.06%)
At close: 4:00PM EDT

15.84 0.00 (0.00%)
After hours: 4:42PM EDT

People also watch
INFIEPZMAEGRMNTASGYP
Full screen
Previous Close15.52
Open15.55
Bid11.15 x 100
Ask18.62 x 100
Day's Range15.46 - 15.87
52 Week Range12.48 - 19.94
Volume876,853
Avg. Volume1,200,232
Market Cap2.37B
Beta1.47
PE Ratio (TTM)-16.23
EPS (TTM)-0.98
Earnings DateNov 1, 2017 - Nov 6, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est17.23
Trade prices are not sourced from all markets
  • Capital Cube9 days ago

    ETFs with exposure to Ironwood Pharmaceuticals, Inc. : September 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Ironwood Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IRWD-US. Comparing the performance and risk of Ironwood Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017
    Capital Cube11 days ago

    Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017

    Categories: Yahoo FinanceGet free summary analysis Ironwood Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Ironwood Pharmaceuticals, Inc. – Progenics Pharmaceuticals, Inc., Synergy Pharmaceuticals, Inc., Nektar Therapeutics, Astrazeneca PLC Sponsored ADR, Sucampo Pharmaceuticals, Inc. Class A, Cumberland Pharmaceuticals Inc. and Synthetic Biologics, Inc. ... Read more (Read more...)

  • Business Wire17 days ago

    Ironwood Pharmaceuticals Announces Leadership Change

    Ironwood Pharmaceuticals, Inc. announced today that Tom Graney, chief financial officer and senior vice president, finance and corporate strategy will leave the company, effective September 13, 2017, to pursue another opportunity.